| Date | Title | Description |
| 14.05.2024 | Hi & Fi Asia-China: Unlocking New Opportunities for Overseas Visitors with Visa Facilitation Policies in 2024 | SHANGHAI, May 14, 2024 /PRNewswire/ -- Hi & Fi Asia-China, as the China station of the Food Ingredients exhibition series (Fi Global), the leading international exhibition for the food and beverage industry, is set to take place from 19... |
| 15.04.2024 | Швейцарии предложено разобраться в себе | - |
| 17.03.2024 | Sweetener Market vs. Fermentation Chemicals Market: A Battle of Sweet Success | The global sweetener market is projected to reach approximately USD 130.6 billion by 2031, while the fermentation chemicals market is expected to hit USD 130.6 billion by 2032. Let's dive into the sweet success of these two booming markets.... |
| 13.03.2024 | Global Oral Solid Dosage Contract Manufacturing Market 2024-2030: Regional Trends for Tablets, Capsules, Powders, and Granules | - |
| 13.03.2024 | $76.6+ Bn Cell Cryopreservation Market to Grow at CAGR of 22.2% , Globally, by 2031 | https://www.alliedmarketresearch.com/cell-cryopreservation-market-A11917
PORTLAND, OREGON, UNITED STATES, March 13, 2024 /EINPresswire.com/ -- 𝐀𝐥𝐥𝐢𝐞𝐝 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐩𝐮𝐛𝐥𝐢𝐬𝐡𝐞𝐝 𝐚 𝐫𝐞𝐩𝐨𝐫𝐭, 𝐭𝐢𝐭𝐥𝐞𝐝, "𝐂𝐞𝐥𝐥 𝐂𝐫𝐲𝐨𝐩𝐫𝐞𝐬𝐞𝐫𝐯𝐚𝐭𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐛𝐲 ...... |
| 13.03.2024 | $69.7 Billion Oral Solid Dosage Contract Manufacturing Market Assessment 2024-2034 Featuring Lonza Group, Catalent, Recipharm | - |
| 11.03.2024 | [Latest] Global Fermentation Chemicals Market Size/Share Worth USD 130.6 Billion by 2032 at a 7.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Gro... | [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Fermentation Chemicals Market size & share revenue was valued at approximately USD 64.5 Billion in 2022 a... |
| 07.03.2024 | Stem Cell Manufacturing Market Worth USD 26.6 billion, Growing At 9.2% CAGR by 2033 - Report By Transparency Market Research, Inc. | - |
| 04.03.2024 | Pharmaceutical Manufacturing Market Projected to Grow at 7.8% CAGR, Reaching $863.6 Bn by 2030 | Vantage Market Research | Vantage Market Research
Pharmaceutical Manufacturing Market Size, Share, Industry Trends, Growth, and Opportunities Analysis by 2030 WASHINGTON, D.C, DISTRICT OF COLUMBIA, UNITED STATES, March 4, 2024 /EINPresswire.com/ -- The Global Pharma... |
| 27.10.2023 | Houston is the 8th best metro for newcomers to make connections, study says | A big city might seem impersonal, but don't be fooled. There's more going on behind the scenes than what a resident might be seeing through their local lens, especially in Houston. A recent LinkedIn study has revealed the best U.S. metros f... |
| 27.10.2023 | What Houston startups are hiring, new high tech athletics facility, and more trending innovation news | Editor's note:Another week has come and gone, and it's time to round up the top headlines from the past few days. Trending Houston tech and startup articles on InnovationMap included which Houston Innovation Awards finalists are hiring, Ric... |
| 25.10.2023 | Developer delivers 120-square-foot life science innovation hub to The Woodlands | A new innovation hub mega campus has opened in The Woodlands.
The Alexandria Center for Advanced Technologies at The Woodlands comes courtesy of California-based Alexandria Real Estate Equities Inc. The campus is home to the first purpose-b... |
| 20.10.2023 | Rice University, Houston Methodist launch state-of-the art human performance center | Rice University and Houston Methodist teamed up to open the new Center for Human Performance this month.
Located in Rice’s Tudor Fieldhouse, just across the street from Houston Methodist's Texas Medical Center offices, the interdisciplinary... |
| 12.10.2023 | 3 Houston college students win big in global Intel AI competition | Three students from Houston Community College Southwest won the top national prize at the 2023 Intel AI Global Impact Festival competition, HCC announced this month.
Sumesh Surendran, Ruben Treviño, and Muskaan Shahzad won the top spot in t... |
| 11.10.2023 | Global accelerator announces latest Houston cohort of early-stage startups | For the eighth time, a global accelerator and venture group has selected five early-stage Houston tech startups to support and help grow.
In partnership with the Downtown Launchpad, gener8tor began its eighth gBETA cohort in September. The ... |
| 11.10.2023 | Innovative California company taps Houston area for purified water projects | Houstonians are used to filtering their water, but few really ponder why they’re doing it.
“Most people, when they think about water stress, they think about water scarcity, like what you see happening in Northern Africa or maybe the Southe... |
| 06.10.2023 | University of Houston lands $63.5M contract with DOD to develop tech for the 'future battlefield' | The University of Houston was recently awarded its largest grant in history—this time, from the U.S. Department of Defense.
The $63.5 million contract aims to support UH in developing analytical modeling and simulation platforms that help t... |
| 06.10.2023 | Texas burger spot takes bite out of innovative, eco-friendly initiative | Hearty Austin-based chain Hopdoddy Burger Bar has unveiled a new lineup of regenerative burgers that are supposed to be better for the planet and the consumer.
The term "regenerative burger" could cause a few head-scratches: Some ... |
| 04.10.2023 | Cancer-fighting startup partners with Houston cell therapy accelerator | When it came time to name their cell therapy startup, Houston life science innovators simply had to look to their calendar.
“I would argue that March is the best month in Houston,” Sarah Hein tells InnovationMap. “We started talking about p... |
| 04.10.2023 | Why this innovator is passionate about uniting Texans in tech and venture | This Friday, Texas innovators across the state will simultaneously show up to support each other, network with potential investors, and talk shop — and it's all thanks to one Austinite.
CS Freeland is organizing the second annual Texas Vent... |
| 02.10.2023 | Space tech startup opens new $40M HQ at Houston Spaceport | Houston aerospace company Intuitive Machines has moved into its new $40 million headquarters at the Houston Spaceport.
Intuitive Machines’ new home supports NASA’s $93 billion Artemis program, which aims to return astronauts to the moon by ... |
| 29.09.2023 | Houston school names digital education expert to newly created position | Rice University is beefing up its digital education efforts with the hiring of an internationally known expert from Duke University.
Shawn Miller is set to join Rice on November 1 in the newly created position of associate provost for digit... |
| 21.09.2023 | Houston program buoys promising cancer research with live-saving innovation | How do you bring promising cancer research to the masses? TMC Innovation's Accelerator for Cancer Therapeutics was established with that question in mind.
Funded by a $5 million grant from CPRIT, or the Cancer Prevention and Research Instit... |
| 21.09.2023 | Inflation: Why Houston employers should prioritize employee financial well-being | Inflation impacts everyone, including individuals, the workforce and business leaders. As the cost of living continues to rise, employees face diminishing purchasing power, shrinking retirement savings and higher stress levels.
In PwC’s 202... |
| 18.09.2023 | Texas organization announces inaugural cohort of social enterprise startups with Web3 tech | A Texas-based accelerator focused on helping BIPOC and female founders on their entrepreneurial journeys announced the inaugural class for its newest accelerator.
DivInc's DWeb for Social Impact Accelerator, a 12-week intensive hybrid progr... |
| 15.09.2023 | New certificate course trains a ready workforce as biotech companies in Pearland take off | Biotech companies in Pearland are thriving, with big names such as Lonza, Millar Inc. Inc., and Abbott all experiencing tremendous growth in recent years.
The only challenge to this success is the increased demand for a faster workforce pip... |
| 13.09.2023 | Founders, investors sound off on Houston's VC scene, energy innovation potential, and more | Last week, nearly 1,000 people convened in Houston to discuss venture capital activity, startups, and decarbonization, and the Houston factor among it all.
On September 7, Venture Houston hosted several keynote addresses and panels througho... |
| 12.09.2023 | Houston edtech startup taps into AI to improve classroom engagement | Not many adages stand the test of time quite like this one: to be the best, learn from the best.
Sage advice, which is why Houston-based Sibme, the learning engagement platform designed by teachers, is introducing an all-new artificial inte... |
| 11.09.2023 | Rice University launches research innovation grant program with VC fund in the works | Over 60 years ago at Rice University, President John F. Kennedy recommitted the country to the Space Race. Now, decades later, the university is announcing its commitment to moonshot innovators.
Rice University's Office of Innovation establ... |
| 07.09.2023 | University of Houston reveals $35M campus transformation ahead of centennial | As the University of Houston gets ready for its centennial in 2027, the school is launching a major transformation to its urban campus. The $35 million project aims to transform several prominent areas of the university grounds and create a... |
| 05.09.2023 | Houston regenerative medicine company opens new lab at UH | Pete O’Heeron wants you to know that “Bohemian Rhapsody” was originally released as a B-side. What does this nugget about Queen have to do with regenerative medicine? For O’Heeron and his company, FibroBiologics, it means everything.
That’s... |
| 05.09.2023 | Houston expert: Cultivate transparency when recruiting flexible workplace positions | How the workplace operates, especially flexible work arrangements, captivate job seekers, prompting many job listings to spotlight remote or hybrid work options. Interestingly, a significant portion of hybrid and remote workers say they wou... |
| 30.08.2023 | How this Houston investor closed a $32M oversubscribed fund in less than a month | It might be cool to arrive fashionably late to a party, but Houston investor Sahir Ali likes to be early when it comes to new technologies.
"What has been a part of my success and has driven a lot of my profesional, scientific, and fin... |
| 29.08.2023 | Report: Rice University again ranks among the top schools in nation | Rice University has earned yet another accolade worth hooting about.
Niche, an education review and ranking website, has named Rice the ninth best college in the U.S., down from No. 6 last year. The Houston university receives an A+ in nine... |
| 22.08.2023 | Houston space tech startup raises $350M series C, clinches unicorn status | Houston has another unicorn — a company valued at $1 billion or more — thanks to a recent round of funding.
Axiom Space released the news this week that it's closed its series C round of funding to the tune of $350 million. While the compan... |
| 01.06.2023 | Lonza to Acquire Synaffix, For Up To €160M | Lonza, a Basel, Switzerland-based manufacturing partner to the pharmaceutical, biotech and nutraceutical markets, acquired Synaffix, an Amsterdam, The Netherlands-based biotechnology company focused on commercializing its clinical-stage tec... |
| 14.10.2022 | Will the Taiwan Semiconductor Manufacturing Company of Drugs Be in East Asia? | On Aug. 25, President Biden signed the monumental $52.7 billion CHIPS and Science Act into law. The legislation is aimed to address the semiconductor manufacturing bottleneck in East Asia, namely the near-monopoly held on the industry by th... |
| 01.09.2022 | ADC Review | Journal of Antibody-drug Conjugates Welcomes Lonza’s Bernhard Stump, Ph.D., as a New Editorial Advisory Board Member | The editorial team of ADC Review | Journal of Antibody-drug Conjugates is extremely proud to announce that Bernhard Stump, Ph.D. Has joined the publication's Editorial Advisory Board.
CHANDLER, Ariz. (PRWEB) September 01, 2022
Today, ADC Re... |
| 22.07.2022 | 'We will continue to fight': Contraceptive companies remain hopeful after House passes bill | A day after the House passed a bill that would protect Americans’ right to contraceptives, biotech execs say they will keep fighting for better access to novel birth control products.
The big question now is whether the legi... |
| 22.07.2022 | Unlikely duo leads bipartisan Senate bill to expand Right to Try into MDMA and psilocybin | Sens. Cory Booker (D-NJ) and Rand Paul (R-KY) likely don’t share much in common when it comes to policy views, but that didn’t stop the pair from introducing a new bill this week that would alter the controversial Right to Try A... |
| 22.07.2022 | Bavarian Nordic's monkeypox vaccine wins positive opinion from EMA committee | With demand rising for Bavarian Nordic’s smallpox vaccine, European officials have given the thumbs up to expand the label to include monkeypox.
Imvanex, marketed as Jynneos in the US, has been approved in Europe to tr... |
| 22.07.2022 | EMA joins regulatory coalition in calling for RWE to be integrated into regulatory decisions | As more and more biotechs are looking into the potential applications of using real-world evidence in regulatory submissions, the European Medicines Agency is calling for more widespread adoption.
EMA endorsed a sta... |
| 22.07.2022 | Vertex wins 'breakthrough' nod for non-opioid pain drug; After US withdrawal, EMA restricts Clovis' Rubraca | Vertex won a breakthrough therapy designation for its non-opioid pain drug, the company announced Friday.
Regulators bestowed the designation upon VX-548, an experimental pill targeting nerve receptors, for the t... |
| 22.07.2022 | Lonza posts double-digit growth in H1 thanks to strong pharma demand | Lonza’s recent building spree and contracts have the manufacturer looking positive as it enters the second half of the year.
According to Lonza’s financial report for H1, which was released on Friday, the Swiss manufa... |
| 22.07.2022 | Idorsia adds Olympic gold medalist and insomnia patient Lindsey Vonn to its celebrity spokesperson roster | After Olympic gold medalist Lindsey Vonn’s first major knee surgery in 2013, she couldn’t sleep. That was the beginning of a cycle of more injuries, added anxiety and stress snowballing into an eventual diagnosis of insom... |
| 22.07.2022 | Sosei Heptares partners with a UK-based cancer research organization to bring its drug to trial | Cancer research has been a focus for Sosei Heptares for several years, and their latest deal hopes to progress one of their newer therapies.
On Friday, the Japanese company inked a deal with Cancer Research UK to bring one ... |
| 22.07.2022 | Updated: Gritstone goes the credit facility route, securing $80M to keep clinical efforts running | A California developer is following up on one of the hottest trends in biotech, taking out a loan to extend its operating runway while the biotech sector takes a beating on Nasdaq.
Vaccine outfit Gritstone bio put out wo... |
| 21.07.2022 | Updated: Spanish heparin manufacturer draws the ire of the FDA in its latest warning over quality concerns | Spanish heparin and API manufacturer Bioiberica is still not in the clear as far as the FDA is concerned, with a new warning letter related to contamination concerns.
The US regulator initially issued a Form 483 to... |
| 06.07.2022 | Flow Chemistry Market Size is projected to reach USD 3 Billion by 2030, growing at a CAGR of 10%: Straits Research | The global flow chemistry market size was worth USD 2 billion in 2021. It is estimated to reach an expected value of USD 3 billion by 2030 at a CAGR of 10% over the forecast period (2022-2030). North America dominated the market. It is esti... |
| 02.06.2022 | Manufacturing roundup: Lonza collaborates with a VC in Israel; Piramal updates one facility while opening a new one | The Swiss CDMO powerhouse Lonza is no stranger to Israel, but a recent collaboration has cemented a new hold over biotech in the region.
According to the company, Lonza and the Israel Biotech Fund, a venture fund invest... |
| 11.03.2022 | Orphazyme admits this may be the end, as it asks court to oversee restructuring | Just a couple weeks after Orphazyme admitted European regulators were unlikely to approve its FDA-rejected drug, the biotech indicated it may shut down entirely.
The Danish biotech said Thursday it is petitioning for an “in-court restructur... |
| 11.03.2022 | Whistleblower complaint alleges more bullying, ethics violations under Lander's leadership — report | Just over a month after the famed yet controversial geneticist and Broad Institute founding director Eric Lander resigned from his role at the White House over harassing staff, a whistleblower report has emerged — and while Lander and the W... |
| 11.03.2022 | Covid-19 roundup: Pfizer readies FDA application for fourth dose to deal with Omicron | As hospitalizations begin to rise again in the UK, Pfizer CEO Albert Bourla told CNBC yesterday that the company will soon submit an application of data to FDA on the need for a fourth dose of the company’s Covid-19 vaccine for all American... |
| 11.03.2022 | Centessa gives Antoine Yver a new role, brings his old colleague on board; Prelude to a change: Jane Huang sets up her next move | Antoine Yver
→ Centessa looked to Daiichi Sankyo to fill the CMO post with Antoine Yver back in May 2021, and now that Yver has garnered a new title, why mess with a good thing?
Yver has been installed as chairman of development, and Centes... |
| 11.03.2022 | Pfizer will not make future investments in Russia but stops short of severing all business ties, Bourla says | Trust is more important than ever in healthcare, but it’s in short supply thanks to the Covid-19 pandemic. More than half (52%) of people around the world lost confidence in the healthcare system to handle major crises, according to a new E... |
| 10.03.2022 | Big Pharma partners join initiative to drive equity and inclusion in digital trials | As digital trials picked up steam amid the pandemic, some said the technology could also be used to address biopharma’s historic lack of diversity in the clinic. But if implemented the wrong way, it could also exacerbate the problem, the Di... |
| 10.03.2022 | Q&A: Franco Stevanto leads family business through pandemic, IPO and onto the global stage | As the US government continues to dump money into vial and packaging manufacturing, Italian vial manufacturer Stevanato Group has taken full advantage.
It broke ground in October on a $145 million manufacturing site in Fishers, IN to bring ... |
| 10.03.2022 | Lonza completes China expansion to support HPAPI production | At the end of 2021, a report from CPhI named Lonza among the CDMO big dogs that will soon be responsible for more than half of the world’s manufacturing capacity by 2025. The Swiss company took another step in that direction Tuesday with th... |
| 10.03.2022 | Three big Congressional hearings next week to set the tenor on Covid-19, drug prices, and ARPA-H | Two Senate committees and a House subcommittee will hold hearings next week taking on Covid-19, future pandemics, the need to lower drug prices in Medicare, and a new health research investor to be known as ARPA-H.
The committees will all s... |
| 28.01.2022 | HaemaLogiX and Lonza Collaborate to Manufacture KappaMab, a Multiple Myeloma Drug Candidate | Lonza to manufacture drug substance for clinical supply of HaemaLogiX's lead multiple myeloma drug candidate, KappaMab, at its new state-of-the-art facility in Guangzhou (CN)
HaemaLogiX will leverage Lonza's regulatory expertise, global man... |
| 18.01.2022 | Lonza : Launches bYlok Technology for the Discovery and Design of Bispecific Antibodies | Lonza launches bYlok™ Technology - a new design engineering approach for bispecific antibodies that can streamline future clinical manufacturing
The platform contributes to solving the light-heavy chain mispairing challenge with an accuracy... |
| 18.01.2022 | Lonza : Forbion, and BioGeneration Ventures Extend Collaboration to Add Development and Manufacturing Services of Small Molecules | Joint Venture Partners Forbion and BioGeneration Ventures extend collaboration with Lonza to include services relating to small molecules for the portfolio companies of both entities
The collaboration continues to provide early de-risking, ... |
| 08.12.2021 | Lonza : Doer Biologics signs licensing agreement with Lonza to develop multi-specific biotherapeutics using XS Pichia | Doer Biologics is utilizing its proprietary MultipleBody® and SMART-VHHBody technology platforms for developing multi-specific biotherapeutics to address unmet medical needs
The license agreement will leverage Lonza's XS®Pichia Expression S... |
| 02.12.2021 | Lonza Walkersville, Inc. Donates to Glade Valley Community Services | "Lonza Walkersville has a long-standing relationship with GVCS and we are proud to continue our partnership and support our local community.” - Philipp Künti, Lonza Walkersville Site Head
WALKERSVILLE, Md. (PRWEB) December 02, 2021
Lon... |
| 23.11.2021 | At busy Visp site, Lonza will up microbial services by 50% | In an effort to up its development of microbial-derived proteins, Swiss CDMO Lonza will invest in its manufacturing capacities in its home country.
The extension will be good to go by the end of this year, the company... |
| 10.11.2021 | Bacthera and Seres Therapeutics Collaborate for Commercial Manufacturing of SER-109, a... | Press Release | Nov 10. 2021 07:07 GMT
SER-109 has the potential to be the first-ever live biotherapeutic product (LBP) to be produced commercially; the collaboration with Seres Therapeutics is a critical milestone for Bacthera, a joint ven... |
| 24.09.2021 | With Maverick now in Takeda's hands, James Scibetta turns the page; Roivant CMO leaves in favor of small IL-2 biotech | James Scibetta
→ Another CEO opportunity has presented itself for James Scibetta, the chief executive of Maverick Therapeutics when Takeda ponied up $525 million in March to buy its T cell collaborator and integ... |
| 24.09.2021 | Capricor's DMD clinical trial meets primary endpoints; Delaware court rules against Takeda in Lupron feud | Beverly Hills, CA-based biotech Capricor Therapeutics revealed today final data from its clinical trial evaluating stem cell therapy CAP-1002 for patients in advanced stages of Duchenne muscular dystrophy.
Duchenne ... |
| 24.09.2021 | AstraZeneca and Merck hope new data can PROpel their PARP inhibitor into first-line prostate cancer | Last year, Clovis’ PARP inhibitor Rubraca beat AstraZeneca and Merck’s blockbuster Lynparza across the finish line in prostate cancer by a matter of days. Now, the pharma partners are looking for a comeback in the first-line s... |
| 23.09.2021 | In step forward for rejuvenation field, researchers turn back the clock on mice hearts | When researchers first started putting CAR-T cells into cancer patients in the 1990s, the cells didn’t do very much. They swam around in the blood, killing very little of what they were meant to kill, before dying a quiet death some months ... |
| 23.09.2021 | Eli Lilly gets behind the latest approach to solving gene therapy's delivery problem | Kunwoo Lee was a graduate student at UC-Berkeley when gene editing pioneer Jennifer Doudna — who happened to work in the same building where he studied — published a paper on CRISPR/Cas9. So he did what any aspiring bioeng... |
| 23.09.2021 | In step forward for rejuvenation field, researchers turn back the clock on mice hearts | Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up... |
| 23.09.2021 | Recall report: Pfizer pulls even more Chantix lots as nitrosamine contamination worries grow | It’s been a month since Pfizer was forced to recall bottles of its anti-smoking drug Chantix, but the counter was set back to zero last week as the company recalled all of its lots of 0.5 mg and 1 mg tablets due to increased lev... |
| 23.09.2021 | Mitch McConnell, top Republicans question Biden on getting ahead of FDA on Covid-19 boosters | Senate Minority Leader Mitch McConnell, Senate Health Committee ranking member Richard Burr and other top Republicans are questioning the Biden administration’s decision to get out in front of the FDA and announce tha... |
| 23.09.2021 | Incyte's ruxolitinib scores its second approval in two days, this time in chronic graft-versus-host disease | A day after approving a topical formulation of Incyte’s cash cow ruxolitinib for atopic dermatitis, regulators are back with more good news for the company’s favorite JAK inhibitor.
The FDA has given Jakafi, the oral ve... |
| 23.09.2021 | Covid-19 roundup: BARDA pumps $60M more into SAB treatment; EMA to decide on boosters next month | SAB Biotherapeutics said Thursday the US federal government is providing it with an additional $60.5 million, and more than $200 million in total, to advance its intravenous polyclonal antibody candidate for the tr... |
| 23.09.2021 | In step forward for rejuvenation field, researchers turn back the clock on mice hearts | When Thomas Braun was starting out as a young professor at Germany’s University of Würzburg in 1997, he decided to try his hand at a new field: heart regeneration, a sci-fi-esque premise that could offer a way to treat patie... |
| 23.09.2021 | In step forward for rejuvenation field, researchers turn back the clock on mice hearts | Lonza will expand its drug development in Switzerland yet again with investments in three of its manufacturing sites, the company announced Wednesday, capping off a very busy year for the Euro giant.
The expansion will feature the addition ... |
| 23.09.2021 | In step forward for rejuvenation field, researchers turn back the clock on mice hearts | Almost a year to the day after Sanofi closed on its $3.7 billion Principia buyout, handing CEO Martin Babler $81 million for his chunk of equity, the biotech exec is ending his sabbatical and getting back to the helm of a startup. And he’s ... |
| 23.09.2021 | AstraZeneca teams up with Imperial offshoot VaxEquity on an RNA 3.0 effort | Robin Shattock
Last year, Imperial College London professor Robin Shattock was given close to $50 million by the UK government to make an RNA-based Covid-19 vaccine. While that fell through, the deal his company just signed... |
| 23.09.2021 | FDA's cancer drug advisors will review 2 more dangling accelerated approvals for multiple myeloma, leukemia | In an attempt to get its house of accelerated approvals in order, the FDA is holding its second adcomm of 2021 to review cancer drugs that won accelerated approvals but failed to confirm clinical benefit in subsequen... |
| 23.09.2021 | Takeda breaks ground on zero-emission site in Asia; Boston Labs emerges from stealth with mobile cell, gene therapy tech | Takeda has broken ground on a $14 million expansion of a Singapore manufacturing site, set to open by 2022. The zero-emissions building will be next to Takeda’s biologics manufacturing plant in JTC’s Woodlands Wafer F... |
| 23.09.2021 | Tillman Gerngross project out of Dartmouth College acquired by Repligen | Hot off of his biotech unicorn landing on the Nasdaq, another project from the lab of Dartmouth College engineering professor Tillman Gerngross has made news, as it’s been acquired by Repligen.
Avitide will now be owned by ... |
| 23.09.2021 | Looking to make donor cells obsolete, an ex-Harvard researcher gets off-the-shelf stem cell biotech off the ground | A stem cell researcher who spent time at the Harvard Stem Cell Institute, the Broad Institute and Brigham and Women’s Hospital launched a new biotech Thursday, and he’s attracted significant blue-chip investment to get thing... |
| 23.09.2021 | Oxford Biomedica sees new investment for manufacturing; Twist gets a partner to help build out discovery libraries | Oxford Biomedica has landed some new cash.
The British gene and cell therapy biotech announced Wednesday it has secured an investment “just over” £50 million from the Serum Institute of India’s investment arm. Funds are ex... |
| 23.09.2021 | In step forward for rejuvenation field, researchers turn back the clock on mice hearts | Summer’s over, but New Jersey-based CDMO Catalent had time to squeak in one last deal.
Catalent has signed an agreement to commercially manufacture Phathom Pharmaceuticals’ lead drug, vonoprazan, for the treatment of gastrointestinal diseas... |
| 23.09.2021 | HHS lines up Novartis, Lilly, AstraZeneca and 3 other drugmakers for fines due to drug discount violations | As drugmakers continue to battle President Biden’s HHS in court over alleged 340B drug discount violations, HHS sent letters on Wednesday to six companies informing them that their violations have been referred to the ... |
| 03.09.2021 | Ziopharm finds new CEO after six-month search; CFO transition at Lonza to take place in December | Kevin Boyle
Less than a year removed from a successful activist attack, Ziopharm Oncology appointed a new CEO this week. Taking the reins will be Kevin Boyle, who comes over after leading Kuur Therapeutics to a $185 milli... |
| 30.06.2021 | Nominate now: InnovationMap announces inaugural Houston innovation awards | Calling all Houston innovators — now is your time to shine.
InnovationMap and its partner, Houston-based Techwave, a global IT services and solutions provider, are pleased to present an inaugural set of awards honoring Houston's innovators ... |
| 24.06.2021 | Lonza : Pinteon Extends Collaboration with Lonza for Manufacturing PNT001, a Novel Tau Antibody Targeting Alzheimer's Disease and Traumatic Brain Injury | Pinteon Extends Collaboration with Lonza for Manufacturing PNT001, a Novel Tau Antibody Targeting Alzheimer's Disease and Traumatic Brain Injury
The agreement builds upon a long-term collaboration with the aim to provide drug substance of P... |
| 17.06.2021 | Houston EV charging station startup gets ready to roll out services across the country | A Houston startup is revving up the region's — and the country's — supply of charging stations for electric vehicles.
The company, Refuel Electric Vehicle Solutions (REVS), recently installed its first two charging stations. They're at two ... |
| 17.06.2021 | Houston expert: 4 questions to ask when hiring employees in other states | A larger share of employees has found themselves working from home, or at least working remote, than ever before and many continue to do so permanently. As employers actively take steps to ensure a strong showing throughout the economic rec... |
| 17.06.2021 | Houston space tech company reveals details on its new $40M facility | A Houston-based space tech company focused on sending the first American spacecraft to the Moon since NASA's Apollo program is planning on expanding its presence here on Earth too.
Intuitive Machines announced its plans to move from its cur... |
| 18.05.2021 | LONZA GROUP AG
Lonza : Launches Next Gene…nd Enhanced Ease of Use | Lonza launches next-generation 4D-Nucleofector®Platform, the leading non-viral cell transfection method for a wide variety of cell types - even those traditionally hard to transfect
Modular design offers unmatched flexibility in scale and t... |
| 18.05.2021 | LONZA GROUP AG
Lonza : Launches Next Generation 4D-Nucleofector Cell Transfection Platform with Proven Performance and Enhanced Ease of Use | Lonza launches next-generation 4D-Nucleofector®Platform, the leading non-viral cell transfection method for a wide variety of cell types - even those traditionally hard to transfect
Modular design offers unmatched flexibility in scale and t... |
| 10.05.2021 | 3 Houston innovators to know this week | Editor's note: In this week's roundup of Houston innovators to know, I'm introducing you to three local innovators across industries — tech, health care, and more — recently making headlines in Houston innovation.
Emily Cisek, founder of Th... |
| 10.05.2021 | Houston ranks among fastest growing tech hubs amid the pandemic, report finds | When Americans think of tech hubs, Silicon Valley or even Austin may initially come to mind. However, Houston appears to be making a play for tech-hub status.
Citing data from career platform LinkedIn, the Axios news website reports that Ho... |
| 07.05.2021 | 5 most popular innovation stories in Houston this week | Editor's note: Another week has come and gone, and it's time to round up the top headlines from the past few days. Trending Houston tech and startup news on InnovationMap included innovators to know, events not to miss this month, big winne... |
| 07.05.2021 | Houston SaaS startup closes $12M series A funding round with support from local VC | A Houston startup with a software-as-a-service platform for the energy transition has announced it closed a funding round with participation from a local venture capital.
Molecule closed its $12 million series A, and Houston-based Mercury F... |
| 06.05.2021 | LONZA GROUP AG
Lonza : Announces Expansion Plans for Next-Generation Mammalian Manufacturing Facilities in Visp (CH) and Portsmouth (US) | Lonza Announces Expansion Plans for Next-Generation Mammalian Manufacturing Facilities in Visp (CH) and Portsmouth (US)
Lonza will invest approximately CHF 850 million to build two new state-of-the-art mammalian facilities and respond to cu... |
